Search details
1.
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trial.
Lancet Oncol
; 21(8): 1066-1076, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32653053
2.
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.
Clin Cancer Res
; 2024 May 21.
Article
in English
| MEDLINE | ID: mdl-38771739
3.
A phase 1 study of the safety, pharmacokinetics and pharmacodynamics of escalating doses followed by dose expansion of the selective inhibitor of nuclear export (SINE) selinexor in Asian patients with advanced or metastatic malignancies.
Ther Adv Med Oncol
; 14: 17588359221087555, 2022.
Article
in English
| MEDLINE | ID: mdl-35432603
4.
Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial.
Lancet Gastroenterol Hepatol
; 6(12): 1025-1035, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34695377
5.
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience.
JCO Precis Oncol
; 52021.
Article
in English
| MEDLINE | ID: mdl-34250396
6.
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC.
J Thorac Oncol
; 15(12): 1928-1934, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32866654
7.
Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial.
Clin Cancer Res
; 24(21): 5272-5281, 2018 11 01.
Article
in English
| MEDLINE | ID: mdl-30045931
8.
Combination of immunotherapy with chemotherapy in first line treatment of metastatic gastric cancer? Too much, too little or just right?
Ann Transl Med
; 8(24): 1692, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-33490204
Results
1 -
8
de 8
1
Next >
>>